2016 Fiscal Year Final Research Report
Monoamine oxidae-induced hydroxyl radical production and cardiomyocyte injury during myocardial ischemia-reperfusion
Project/Area Number |
26462774
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Emergency medicine
|
Research Institution | National Cardiovascular Center Research Institute |
Principal Investigator |
AKIYAMA Tsuyoshi 国立研究開発法人国立循環器病研究センター, 研究所, 室長 (70202554)
|
Co-Investigator(Renkei-kenkyūsha) |
INAGAKI Tadakatsu 独立行政法人国立循環器病研究センター, 血管生理学部, 上級研究員 (20638366)
SHIMIZU Shuji 独立行政法人国立循環器病研究センター, 循環動態制御部, 上級研究員 (80443498)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Keywords | 心臓 / 虚血・再灌流 / モノアミン / ヒドロキシラジカル / マイクロダイアリシス法 |
Outline of Final Research Achievements |
We applied microdialysis technique to the heart of anesthetized rats. Dialysate samples were collected during 30 min of induced ischemia followed by 60 min of reperfusion. We monitored dialysate 3,4-dihydrobenzoic acid (3,4-DHBA) concentration as an index of hydroxyl radical production using a trapping agent (4-hydroxybenzoic acid), and dialysate myoglobin concentration as an index of cardiomyocyte injury in the ischemic region. Dialysate 3,4-DHBA concentration increased during ischemia and further increased after reperfusion. Pargyline, a MAO inhibitor, suppressed the averaged increase in dialysate 3,4-DHBA concentration during ischemia and reperfusion. Dialysate myoglobin concentration increased during ischemia and further increased after reperfusion. Pargyline reduced the averaged dialysate myoglobin concentration during ischemia and reperfusion. MAO plays a significant role in hydroxyl radical production and cardiomyocyte injury during ischemia and after reperfusion.
|
Free Research Field |
循環生理学
|